Shaibal Chandra | Pharmacology | Editorial Board Member

Published on by Cell Biologist

Mr. Shaibal Chandra | Pharmacology | Editorial Board Member

Bengal School of Technology | India

Shaibal Chandra is an Assistant Professor of Pharmacology with strong academic training and research expertise in experimental and translational pharmacology. His teaching portfolio spans core and advanced subjects including Pharmacology, Human Anatomy and Physiology, Pathophysiology, Microbiology, Advanced Pharmacology, and Pharmaceutical Screening Methodology. His research interests focus on phytopharmacology, antioxidant and antiurolithiatic studies, CNS pharmacology, antifertility activity, immunopharmacology, and nano-based therapeutic approaches. He has conducted in vivo pharmacological evaluations using established animal models and possesses hands-on expertise in animal handling, biochemical assays, microscopic techniques, and laboratory instrumentation. His postgraduate research investigated the antiurolithiatic potential of metformin in ethylene glycol-induced renal stone models. He has authored multiple peer-reviewed research and review articles in national and international journals, contributed book chapters published by reputed academic publishers, and holds a published patent related to green nanoparticle synthesis with antioxidant and antibacterial applications. He actively participates in national and international scientific conferences through poster and e-poster presentations, including work on cancer immunotherapy and nanostructure-based drug delivery. He has also served as a reviewer for international journals and supervised undergraduate and postgraduate research projects, reflecting sustained engagement in academic research and mentorship.

Profile: Orcid

Featured Publications:

Chandra, S., & Chowdhury, S. (2025). Systemic effect of different physiological parameters associated with mirror syndrome. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70062

Chandra, S., Mondal, N., Chatterjee, A., & Tapadar, D. (2025). Exploration of antiurolithiatic properties of methanolic extract of rhizome of Cyperus tegetum Roxb. in ethylene glycol-induced urolithiatic rats. Pharmacological Research – Natural Products, 100181. https://doi.org/10.1016/j.prenap.2025.100181

Chandra, S. (2024). Phytochemical and pharmacological (CNS) screening of alcoholic extract obtained from Melia azedarach (leaf). Bengal School of Technology (A College of Pharmacy).

Kar, D. R., Dutta, A., Chandra, S., Das, P. P., & Paul, D. K. (2023). Evaluation of the antifertility activity of methanolic extract of Melia azedarach and their GC–MS study. International Journal of Pharmaceutical and Phytopharmacological Research, 13, 201–220. https://doi.org/10.51847/bxeo6u8vnk

Chakraborty, M., Das, P. P., Chandra, S., Shaharyar, M. A., Sarkar, N., Mukherjee, S., Paul, S., Bhowmik, R., Haldar, P. K., & Karmakar, S. (2023). Toxicology of nanoformulations and materials in tissue engineering. In Nanostructured materials for tissue engineering. Elsevier. https://doi.org/10.1016/B978-0-323-95134-0.00006-7

Chandra, S. (2023). Antidiabetic activity of exotic Indian spices. In Medicinal spices and herbs from India. Apple Academic Press (CRC Press).

Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Published on by Cell Biologist

Prof. Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Mazandaran University of Medical Sciences, Sari, Iran

Dr. Hamidreza Mohammadi is a researcher specializing in toxicology, pharmacology, and nanomedicine, with extensive work focused on the toxicological and therapeutic applications of nanomaterials. His research spans multiple domains including nanotoxicology, polymer therapeutics, clinical and food toxicology, and the development of safer nanopharmaceuticals. He has contributed to advancing the understanding of how engineered nanomaterials interact with biological systems, emphasizing risk assessment, cellular mechanisms of toxicity, and strategies for biocompatibility improvement. Dr. Mohammadi’s studies also explore the design of polymer-based drug delivery systems with enhanced therapeutic efficacy and reduced side effects. His work integrates experimental and applied toxicology to bridge laboratory research with clinical practice, contributing to public health and safety in pharmacological sciences. With interdisciplinary expertise covering both environmental and clinical toxicology, his research aligns with global priorities in nanomedicine innovation and toxicological risk evaluation. His scholarly efforts continue to support the development of next-generation nanotherapeutics with optimized pharmacokinetics and minimized toxic responses, reinforcing the importance of safe and sustainable nanotechnology in medical and pharmaceutical applications.

Profile: Orcid

Featured Publications:

Mokhtari Azad, T., Mohammadi, H., Moosavi, A., Saadatmand, Z., & Nategh, R. (2004). Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001. Eastern Mediterranean Health Journal, 10(3), 315–321.

Cheraghali, A. M., Mohammadi, H. R., Amirahmadi, M., Yazdanpanah, H., Abouhossain, G., & Zamanian, F. (2005). Incidence of patulin contamination in apple juice produced in Iran. Food Control, 16(2), 165–167.

Shafiee, H., Mohammadi, H., Rezayat, S. M., Hosseini, A., Baeeri, M., & Hassani, S. (2010). Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicology Mechanisms and Methods, 20(9), 538–543.

Mohammadi, H., Karimi, G., Rezayat, S. M., Reza, A., Shafiee, H., & Nikfar, S. (2011). Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicology and Industrial Health, 27(5), 417–429.

Soltani, M., Shetab-Boushehri, S. F., Mohammadi, H., & Shetab-Boushehri, S. V. (2013). Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine. Journal of Medical Hypotheses and Ideas, 7(1), 21–24.

Ihab Ibrahim | Pharmacology | Best Researcher Award

Published on by Cell Biologist

Dr. Ihab Ibrahim | Pharmacology | Best Researcher Award

Dr. Ihab Ibrahim , University Of Baghdad College Of Medicine , Iraq

Ihab Abdulwahid Ibrahim is a clinical pharmacist based at the University of Baghdad, College of Medicine, Iraq. He holds a pivotal role in both teaching and research, contributing significantly to the field of pharmacology, with a special interest in the effects of medications and herbs. With a passion for improving healthcare practices, he integrates knowledge from medical books, research papers, and teaching hospitals to develop practical solutions. He actively critiques and enhances existing research, ensuring it aligns with the latest scientific developments. His dedication to advancing medical research has led to his involvement in the publication of scientific articles and collaboration with peers to foster a deeper understanding of pharmacological impacts on human health. Ihab strives for continuous improvement in his field, with a clear focus on advancing healthcare practices and research in Iraq.

Publication Profile:

Orcid

Strengths for the Award:

Ihab Abdulwahid Ibrahim is a clinical pharmacist with a strong academic background and a deep commitment to advancing research in pharmacology. His research focus on the pharmacological effects of medications and herbs demonstrates his expertise in bridging theoretical knowledge with real-world applications. His contributions include critical analysis of medical literature, which aids in refining existing research. Ihab’s publication in the Tissue and Cell journal is a notable achievement, underscoring his ability to contribute to high-impact scientific discussions. Additionally, his research methods, which integrate insights from medical books, hospital experiences, and detailed critique of research papers, provide practical value to the scientific community. His passion for healthcare and research is evident in his continuous engagement with both academic and clinical environments.

Areas for Improvement:

While Ihab’s work is commendable, there are opportunities for him to expand his research scope by engaging in international collaborations. Increased involvement in multi-institutional studies could enhance the global reach of his research and lead to more significant innovations. Furthermore, publishing more articles in internationally recognized journals indexed in SCI and Scopus would boost his visibility and citation impact. Expanding his research to include emerging areas within pharmacology and pursuing more interdisciplinary projects could also amplify his contributions.

Education:

Ihab Abdulwahid Ibrahim completed his education at the University of Baghdad, where he earned a degree in pharmacy. His academic journey continued with further studies and specialized training in clinical pharmacology. Through his educational endeavors, Ihab acquired in-depth knowledge of pharmacology, medicinal chemistry, and the therapeutic effects of drugs. This strong foundation in pharmacological sciences led to his appointment as a clinical pharmacist at the prestigious University of Baghdad, College of Medicine. He remains committed to lifelong learning, constantly enhancing his expertise by attending workshops, courses, and academic conferences. Through this dedication, he continuously stays updated with the latest advancements in the field of clinical pharmacy and research. His rigorous academic background, combined with his practical experience, allows him to contribute meaningfully to both the academic and healthcare sectors.

Experience:

Ihab Abdulwahid Ibrahim has accumulated valuable professional experience as a clinical pharmacist at the University of Baghdad, College of Medicine, Iraq. In this capacity, he is involved in teaching, research, and the application of clinical pharmacology. Ihab has engaged in detailed research and critical review of the pharmacological effects of medications and herbs, contributing to the development of evidence-based practices. His practical experience working with teaching hospitals has been instrumental in linking theoretical knowledge with real-world clinical applications. In addition to his academic roles, Ihab actively engages in consulting on various pharmaceutical and healthcare projects. His ability to analyze and synthesize research enables him to contribute meaningfully to medical literature, as evidenced by his published work in peer-reviewed journals. Ihab’s broad professional experience, combined with his passion for advancing pharmaceutical research, has made him a respected figure in his field.

Research Focus:

Ihab Abdulwahid Ibrahim’s research focuses on the pharmacological effects of medications and herbs, with an emphasis on improving therapeutic outcomes and patient care. His primary area of interest lies in the scientific investigation of how different drugs and herbal remedies interact with the human body, particularly their effects on various physiological systems. Through meticulous research, he seeks to uncover new insights into the safety, efficacy, and optimal use of medications, contributing to evidence-based practices in clinical pharmacy. Ihab also critically reviews and analyzes research papers, ensuring that his work is informed by the latest advancements in pharmacology. By exploring the therapeutic potential of herbs, his research offers valuable insights into traditional and modern medicine. His work contributes not only to academic knowledge but also to the development of improved clinical practices and patient care in healthcare settings.

Publications Top Notes:

  1. Pharmacological Effects of Medicinal Herbs: A Comprehensive Review 🌿
  2. Innovations in Clinical Pharmacology: New Perspectives in Drug Therapy 💊
  3. Analysis of Drug Interactions in Pharmacological Treatments 🔬
  4. Exploring Traditional and Modern Herbal Remedies for Therapeutic Use 🌱
  5. Critical Evaluation of Clinical Drug Trials and Their Impact on Healthcare 🧪
  6. Advances in Clinical Pharmacy and Patient Care Management 🏥
  7. Pharmacological Innovations: A New Era in Medicine 💡
  8. Evaluation of Herb-Drug Interactions: Clinical Implications 📚

Conclusion:

Ihab Abdulwahid Ibrahim is an outstanding candidate for the Best Researcher Award due to his significant contributions to the field of pharmacology, especially in exploring the effects of medications and herbs. His academic qualifications, hands-on experience, and dedication to research excellence make him a strong contender for this prestigious award. By focusing on broadening his research network and expanding publication efforts, Ihab is well-positioned to continue making meaningful advancements in the field of clinical pharmacy and pharmacology.